{"product_id":"global-cell-and-gene-therapy-manufacturing-quality-control-supply-demand-and-key-producers-2023-2029","title":"Global Cell and Gene Therapy Manufacturing Quality Control Supply, Demand and Key Producers, 2023-2029","description":"\u003cp\u003eGlobal Cell and Gene Therapy Manufacturing Quality Control Supply, Demand and Key Producers, 2023-2029\u003cbr\u003e\nThe global Cell and Gene Therapy Manufacturing Quality Control market size is expected to reach $ 1325.4 million by 2029, rising at a market growth of 18.2% CAGR during the forecast period (2023-2029).\u003c\/p\u003e\n\n\u003cp\u003eThis report studies the global Cell and Gene Therapy Manufacturing Quality Control demand, key companies, and key regions.\u003c\/p\u003e\n\n\u003cp\u003eThis report is a detailed and comprehensive analysis of the world market for Cell and Gene Therapy Manufacturing Quality Control, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Cell and Gene Therapy Manufacturing Quality Control that contribute to its increasing demand across many markets.\u003c\/p\u003e\n\n\u003cp\u003eHighlights and key features of the study\u003c\/p\u003e\n\n\u003cp\u003eGlobal Cell and Gene Therapy Manufacturing Quality Control total market, 2018-2029, (USD Million)\u003c\/p\u003e\n\n\u003cp\u003eGlobal Cell and Gene Therapy Manufacturing Quality Control total market by region \u0026amp; country, CAGR, 2018-2029, (USD Million)\u003c\/p\u003e\n\n\u003cp\u003eU.S. VS China: Cell and Gene Therapy Manufacturing Quality Control total market, key domestic companies and share, (USD Million)\u003c\/p\u003e\n\n\u003cp\u003eGlobal Cell and Gene Therapy Manufacturing Quality Control revenue by player and market share 2018-2023, (USD Million)\u003c\/p\u003e\n\n\u003cp\u003eGlobal Cell and Gene Therapy Manufacturing Quality Control total market by Type, CAGR, 2018-2029, (USD Million)\u003c\/p\u003e\n\n\u003cp\u003eGlobal Cell and Gene Therapy Manufacturing Quality Control total market by Application, CAGR, 2018-2029, (USD Million).\u003c\/p\u003e\n\n\u003cp\u003eThis reports profiles major players in the global Cell and Gene Therapy Manufacturing Quality Control market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bio-Rad Laboratories,Inc., QIAGEN, Charles River Laboratories International, Inc., Lonza Group AG, Bio-Techne Corporation, Merck KGaA, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific, Inc. and Intertek Group Plc, etc.\u003c\/p\u003e\n\n\u003cp\u003eThis report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.\u003c\/p\u003e\n\n\u003cp\u003eStakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Cell and Gene Therapy Manufacturing Quality Control market.\u003c\/p\u003e\n\n\u003cp\u003eDetailed Segmentation:\u003c\/p\u003e\n\n\u003cp\u003eEach section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.\u003c\/p\u003e\n\n\u003cp\u003eGlobal Cell and Gene Therapy Manufacturing Quality Control Market, By Region:\u003cbr\u003e\nUnited States\u003cbr\u003e\nChina\u003cbr\u003e\nEurope\u003cbr\u003e\nJapan\u003cbr\u003e\nSouth Korea\u003cbr\u003e\nASEAN\u003cbr\u003e\nIndia\u003cbr\u003e\nRest of World\u003c\/p\u003e\n\n\u003cp\u003eGlobal Cell and Gene Therapy Manufacturing Quality Control Market, Segmentation by Type\u003cbr\u003e\nSterility Testing\u003cbr\u003e\nPurity Testing\u003cbr\u003e\nPotency Testing\u003cbr\u003e\nIdentity Testing\u003cbr\u003e\nOthers\u003c\/p\u003e\n\n\u003cp\u003eGlobal Cell and Gene Therapy Manufacturing Quality Control Market, Segmentation by Application\u003cbr\u003e\nPharmaceutical \u0026amp; Biotechnology Companies\u003cbr\u003e\nContract Manufacturing Organizations\u003c\/p\u003e\n\n\u003cp\u003eCompanies Profiled:\u003cbr\u003e\nBio-Rad Laboratories,Inc.\u003cbr\u003e\nQIAGEN\u003cbr\u003e\nCharles River Laboratories International, Inc.\u003cbr\u003e\nLonza Group AG\u003cbr\u003e\nBio-Techne Corporation\u003cbr\u003e\nMerck KGaA\u003cbr\u003e\nF. Hoffmann-La Roche Ltd\u003cbr\u003e\nThermo Fisher Scientific, Inc.\u003cbr\u003e\nIntertek Group Plc\u003cbr\u003e\nEurofins Scientific S.E.\u003c\/p\u003e\n\n\u003cp\u003eKey Questions Answered\u003c\/p\u003e\n\n\u003cp\u003e1. How big is the global Cell and Gene Therapy Manufacturing Quality Control market?\u003c\/p\u003e\n\n\u003cp\u003e2. What is the demand of the global Cell and Gene Therapy Manufacturing Quality Control market?\u003c\/p\u003e\n\n\u003cp\u003e3. What is the year over year growth of the global Cell and Gene Therapy Manufacturing Quality Control market?\u003c\/p\u003e\n\n\u003cp\u003e4. What is the total value of the global Cell and Gene Therapy Manufacturing Quality Control market?\u003c\/p\u003e\n\n\u003cp\u003e5. Who are the major players in the global Cell and Gene Therapy Manufacturing Quality Control market?\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"September, 2023 \/ 111 Pages \/ MCW16232408","offer_id":47647505023282,"sku":null,"price":5376.0,"currency_code":"USD","in_stock":true},{"title":"September, 2023 \/ 111 Pages \/ MCW16232409","offer_id":47647505056050,"sku":null,"price":5376.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/global-cell-and-gene-therapy-manufacturing-quality-control-supply-demand-and-key-producers-2023-2029","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}